T Therapeutics Appoints Kirsty Crame Chief Development Officer
T-Therapeutics announced on November 5 that Kirsty Crame joined as chief development officer to oversee translational and clinical development alongside its Series B close. No predecessor or separate effective date was identified; the reason…
